Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anastrozole (arimidex) (1 trial)
capecitabine (xeloda) (1 trial)
fulvestrant (faslodex) (1 trial)
durvalumab (imfinzi) (1 trial)
fluorouracil (efudex) (1 trial)
mitomycin (mutamycin) (1 trial)
panitumumab (vectibix) (1 trial)
tremelimumab (Imjudo) (1 trial)
Anus Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (8 total)